humanitarian
Archived signal Translated · Español · 2–5m lag
Medicinas humanas Informe Público Europeo de Evaluación (EPAR): Onpattro, patrisiran, Fecha de autorización: 27/08/2018, Revisión: 16, Estado: Autorizado
Medicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Osenvelt, denosumab, Fecha de autorización: 14/02/2025, Revisión: 6, Estado: Autorizado
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): Onpattro, patrisiran, Fecha de autorización: 27/08/2018, Revisión: 16, Estado: AutorizadoEMA What Is NewMedicinas humanas Informe Público Europeo de Evaluación (EPAR): Onpattro, patrisiran, Fecha de autorización: 27/08/2018, Revisión: 16, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 22, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 22, Status: AuthorisedEMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Litfulo, ritlecitinib, Fecha de autorización: 15/09/2023, Revisión: 5, Estado: AutorizadoEMA What Is NewMedicamentos para el hombre Informe Público Europeo de Evaluación (EPAR): Litfulo, ritlecitinib, Fecha de autorización: 15/09/2023, Revisión: 5, Estado: AutorizadoEMA What Is NewHuman medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 13, Status: Autho…EMA What Is NewHuman medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 13, Status: Autho…4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources